Bone Biologics Corp — Form D/A

Bone Biologics Corp of BURLINGTON, MA, a company, filed a Form D amendment with the SEC on 2018-03-30. The offering totals $10.0M, of which $1.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
JEFFREY R FRELICKExecutive OfficerBurlington,, MA
John BoothDirectorSAINT-SAUVEUR, A8
Deina H WalshExecutive OfficerBurlington, MA
Siddhesh R AngleDirectorBurlington, MA
Erick R LuceraDirectorBurlington, MA
Jeffrey FrelickExecutive OfficerBurlington, MA
Benjamin WuDirectorNew York, NY
Deina R WalshExecutive OfficerBurlington, MA
Stephen R LaNeveDirectorBurlington, MA
Stephen R LaNeveExecutive OfficerBurlington, MA
Don R HankeyDirectorBurlington, MA
Bret R HankeyDirectorBurlington, MA
Jimmy R DelshadDirectorBurlington, MA
Bruce R StroeverDirectorBurlington, MA
John R BoothDirectorBurlington, MA
Jeff R FrelickExecutive OfficerBurlington, MA
Chia SooDirectorBoston, MA
Jimmy DelshadDirectorBoston, MA
William CoffinDirectorBoston, MA
Bruce StroeverDirectorBoston, MA
Jeff FrelickExecutive OfficerBoston, MA
Deina WalshExecutive OfficerBoston, MA
Steve La NeveExecutive OfficerBoston, MA

Other filings by this issuer (4)

FiledFormOfferingSold
2023-11-29D$729K$729K
2018-07-23D$5.9M$5.9M
2017-08-30D$10.0M$1.4M
2016-03-23D$4.5M

More